IndyGeneUS AI

About:

IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.

Website: https://indygeneus.ai/

Twitter/X: indygeneus_ai

Top Investors: Founder Institute, Merck Global Health Innovation Fund, Johnson & Johnson, Voltron Capital, Johnson & Johnson Robotics and Digital Solutions

Description:

IndyGeneUS AI is a Black-Owned & Service-Disabled Veteran-Owned Small Business (SDVOSB) genomics company creating the world’s largest digital blockchain-encrypted repository of indigenous and diasporic African clinical and genomic data. Our proprietary technology can detect novel signature sequences, biomarkers, and polygenic risk scores by integrating “multi-omics” data, electronic healthcare record (EHR) data, and textual information such as scientific manuscripts.

Total Funding Amount:

$1.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Washington, District of Columbia, United States

Founded Date:

2021-06-14

Contact Email:

info(AT)indygeneus.ai

Founders:

Bradford Wilson, Wilmot Allen, Yusuf Henriques

Number of Employees:

11-50

Last Funding Date:

2022-12-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai